Work

Tositumomab and Iodine I-131 Tositumomab (Bexxar® therapeutic regimen) for Non-Hodgkin's Lymphoma Patients Who Progressed After Treatment with Rituximab: Long Term Follow-up of a Multi-Center Phase II Study.

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.2732.2732

Authors: Sandra J Horning, Anas Younes, Donald Podoloff, Thierry J Horner, Vanessa C Williams, Christina Vleisides, Michael Goris

Institutions: Stanford University, The University of Texas MD Anderson Cancer Center, GlaxoSmithKline (United States)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2553039987

FWCI: 0.21

Cites:

Cited by: 1

Related to: 10